Addendum: Multipeptide vaccines for melanoma in the adjuvant setting: long-term survival outcomes and post-hoc analysis of a randomized phase II trial.

ABSTRACT:

SUBMITTER: Ninmer EK 

PROVIDER: S-EPMC12413449 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature